These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35371927)

  • 1. Myocardial extracellular volume assessed by cardiovascular magnetic resonance may predict adverse left ventricular remodeling in rheumatic heart disease after valvular surgery.
    Li S; Wang S; Yu J; Sun J; Cheng W; Liu J; Pu H; Chen Y; Peng L
    Quant Imaging Med Surg; 2022 Apr; 12(4):2487-2497. PubMed ID: 35371927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Speckle-Tracking Echocardiography Predicts Adverse Left Ventricular Remodeling After Valve Replacement in Rheumatic Mitral Stenosis.
    Zhang X; Zhang J; Cai Y; Li Y; Qin S; Li J; Zeng D; Huang T; Huang LL; Zhong Y; Wei L; Wu J
    Ther Clin Risk Manag; 2023; 19():755-766. PubMed ID: 37750070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular volume fraction assessed using cardiovascular magnetic resonance can predict improvement in left ventricular ejection fraction in patients with dilated cardiomyopathy.
    Inui K; Asai K; Tachi M; Yoshinaga A; Izumi Y; Kubota Y; Murai K; Tsukada YT; Amano Y; Kumita S; Shimizu W
    Heart Vessels; 2018 Oct; 33(10):1195-1203. PubMed ID: 29560528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging.
    Xu HY; Yang ZG; Zhang Y; Peng WL; Xia CC; Li ZL; He Y; Xu R; Rao L; Peng Y; Li YM; Gao HL; Guo YK
    BMC Cardiovasc Disord; 2020 Jan; 20(1):12. PubMed ID: 31924159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume.
    Miller CA; Naish JH; Bishop P; Coutts G; Clark D; Zhao S; Ray SG; Yonan N; Williams SG; Flett AS; Moon JC; Greiser A; Parker GJ; Schmitt M
    Circ Cardiovasc Imaging; 2013 May; 6(3):373-83. PubMed ID: 23553570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CMR-derived extracellular volume fraction (ECV) in asymptomatic heart transplant recipients: correlations with clinical features and myocardial edema.
    Yuan Y; Cai J; Cui Y; Wang J; Alwalid O; Shen X; Cao Y; Zou Y; Liang B
    Int J Cardiovasc Imaging; 2018 Dec; 34(12):1959-1967. PubMed ID: 30056496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1.
    Treibel TA; Fridman Y; Bering P; Sayeed A; Maanja M; Frojdh F; Niklasson L; Olausson E; Wong TC; Kellman P; Miller CA; Moon JC; Ugander M; Schelbert EB
    JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):44-54. PubMed ID: 31103587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse myocardial fibrosis by T1 mapping is associated with heart failure in pediatric primary dilated cardiomyopathy.
    Al-Wakeel-Marquard N; Seidel F; Herbst C; Kühnisch J; Kuehne T; Berger F; Klaassen S; Messroghli DR
    Int J Cardiol; 2021 Jun; 333():219-225. PubMed ID: 33737165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial Extracellular Volume Fraction Allows Differentiation of Reversible Versus Irreversible Myocardial Damage and Prediction of Adverse Left Ventricular Remodeling of ST-Elevation Myocardial Infarction.
    Chen BH; An DA; He J; Xu JR; Wu LM; Pu J
    J Magn Reson Imaging; 2020 Aug; 52(2):476-487. PubMed ID: 31943526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.
    aus dem Siepen F; Buss SJ; Messroghli D; Andre F; Lossnitzer D; Seitz S; Keller M; Schnabel PA; Giannitsis E; Korosoglou G; Katus HA; Steen H
    Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):210-6. PubMed ID: 25246502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of native T1 mapping and myocardial extracellular volume fraction in patients with nonischemic dilated cardiomyopathy: A systematic review and meta-analysis.
    Tao M; Dhaliwal S; Ghosalkar D; Sheng S; Dianati-Maleki N; Tam E; Rahman T; Mann N; Kort S
    Int J Cardiol Heart Vasc; 2024 Apr; 51():101339. PubMed ID: 38371310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial ECV Fraction Assessed by CMR Is Associated With Type of Hemodynamic Load and Arrhythmia in Repaired Tetralogy of Fallot.
    Chen CA; Dusenbery SM; Valente AM; Powell AJ; Geva T
    JACC Cardiovasc Imaging; 2016 Jan; 9(1):1-10. PubMed ID: 26684969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial extracellular remodeling is associated with ventricular diastolic dysfunction in children and young adults with congenital aortic stenosis.
    Dusenbery SM; Jerosch-Herold M; Rickers C; Colan SD; Geva T; Newburger JW; Powell AJ
    J Am Coll Cardiol; 2014 May; 63(17):1778-85. PubMed ID: 24632273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is experienced pregnancy in women with repaired tetralogy of Fallot related to diffuse myocardial fibrosis?
    de Lange C; Quattrone A; Try K; Bakke AH; Borger Kvaslerud A; Haugaa K; Estensen ME
    Int J Cardiol; 2021 Dec; 344():95-102. PubMed ID: 34555445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF.
    Su MY; Lin LY; Tseng YH; Chang CC; Wu CK; Lin JL; Tseng WY
    JACC Cardiovasc Imaging; 2014 Oct; 7(10):991-7. PubMed ID: 25240451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction.
    Rommel KP; von Roeder M; Latuscynski K; Oberueck C; Blazek S; Fengler K; Besler C; Sandri M; Lücke C; Gutberlet M; Linke A; Schuler G; Lurz P
    J Am Coll Cardiol; 2016 Apr; 67(15):1815-1825. PubMed ID: 27081022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
    Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early myocardial and skeletal muscle interstitial remodelling in systemic sclerosis: insights from extracellular volume quantification using cardiovascular magnetic resonance.
    Barison A; Gargani L; De Marchi D; Aquaro GD; Guiducci S; Picano E; Cerinic MM; Pingitore A
    Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):74-80. PubMed ID: 25190071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial Extracellular Volume Fraction and T1 Mapping by Cardiac Magnetic Resonance Compared Between Patients With and Without Type 2 Diabetes, and the Effect of ECV and T2D on Cardiovascular Outcomes.
    Laohabut I; Songsangjinda T; Kaolawanich Y; Yindeengam A; Krittayaphong R
    Front Cardiovasc Med; 2021; 8():771363. PubMed ID: 34950715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.